Book Value per Share: Adlai Nortye Ltd (ANL)

Graphic logo of Adlai Nortye Limited (ANL)

Optimized hub-based supply logistics ensure the stability of Adlai Nortye Ltd. (ANL), and this chart on the GURU.Markets terminal displays book value per share data, where the indicator value is 3.36. However, geopolitical discord between China and the West creates sales risks. Furthermore, stringent FDA requirements and the high cost of molecular oncology developments necessitate colossal capital for survival.

ANL (Adlai Nortye Ltd.) Book Value per Share history from 02/21/2024 to 10/29/2026
Flagship merchandise of Adlai Nortye Ltd

For Adlai Nortye Ltd. (ANL), the net asset value per share reflects the real value of capital deployed in costly oncology research and expansion into the US and Chinese markets. This metric is calculated as the difference between the company's total assets and liabilities divided by the number of shares, allowing investors to verify the market price against the actual value of assets to avoid overpaying during a trend reversal.

Competitor analysis

ONC - Net Assets per Single Share|HALO - Net Assets per Single Share|RVMD (Revolution Medicines) - Book Value per Share|ascentage.com (AAPG) - Accounting Value per Share|CGON (CG Oncology) - Book Value per Share|Book Value per Share URGN|Net Assets per Single Share Bicara Bio BCAX|Equity per Share Personalis Genomics (PSNL)|Erasca, Inc. - Book Value per Share|Accounting Value per Share delcath.com DCTH|YMAB (Y-mAbs Therapeutics, Inc.) - Book Value per Share|AURA: Net Asset Value per Share|Net Assets per Single Share candeltx.com CADL|Accounting Value of a Share Accuray, Inc.|SLS - Accounting Value per Share|Accounting Value of a Share actuatetherapeutics.com|Book Value per Share CTOR (Citius Oncology)|Accounting Value per Share tuhurabio.com HURA|Accounting Value per Share TARA (Protara)|Fate Pharma - Book Value per Share|Net Assets per Single Share Aadi Bio (WHWK)|TCRX - Accounting Value of a Share|Book Value per Share CSBR|XBiotech (XBIT) - Net Asset Value per Share|CVM (CEL-SCI Corp.) - Book Value per Share|Book Value per Share OS Therapies, Inc.|Book Value per Share Radiopharm Theranostics Limited RADX|Equity per Share ARTV (artivabio.com)|Net Assets per Single Share Veru VERU|Net Assets per Single Share Tempest Therapeutics Inc TPST|Xilio - Book Value per Share|RENB - Book Value per Share|muraloncology.com - Book Value per Share|Net Assets per Share Kairos Pharma|OKUR - Accounting Value per Share|Accounting Value of a Share GDTC|Net Assets per Single Share Curis, Inc. CRIS|Equity per Share APLM (apollomicsinc.com)|THAR: Net Assets per Single Share|Advanced Biomed Inc. - Net Asset Value per Share|Net Assets per Single Share Genprex (GNPX)|Calidi Biotherapeutics (CLDI) - Accounting Value of a Share|SBFM - Accounting Value per Share|Book Price of a Share Xenetic Biosciences, Inc.|Accounting Value per Share SLRX (Salarius Pharmaceuticals)|Net Asset Value per Share purple-biotech.com|American Oncology Network - Book Value per Share|Net Asset Value per Share BeiGene Ltd. BGNE|Accounting Value per Share Checkpoint Therapeutics, Inc|elevationoncology.com - Accounting Value of a Share|ICAD - Net Assets per Single Share|Ikena Oncology, Inc. (IKNA) - Net Assets per Single Share|NTBL - Accounting Value per Share|Viracta Therapeutics, Inc. (VIRX) - Book Price of a Share|Book Value per Share MorphoSys Corp (MOR)|Equity per Share NAYA Biosciences Corp (NAYA)|AAPGV (Ascentage Pharma Group) - Accounting Value per Share